The Advertising Standards Council of India (ASCI) has found all 60 nutraceutical advertisements it completed reviewing between July and September 2026 to be in violation of its advertising code. The findings raise concerns about misleading health promises and insufficient scientific evidence.
ASCI Review Finds Widespread Violations in Nutraceutical Advertising
India’s growing nutraceutical industry is facing increased scrutiny over how brands advertise health and wellness products. In its latest report, titled A Pill for Thought: Review of Health and Wellness Claims in Nutraceutical Advertising, the Advertising Standards Council of India examined 61 advertisements published between July and September 2026.
Of these, 60 cases had completed the review process, and all 60 were found to require modification under the ASCI Code. One advertisement remained under review when the findings were released on October 28.
The report identified concerns involving weight management, anti-ageing, skincare, UV protection and respiratory health claims. Some advertisements also made promises relating to conditions such as asthma, chronic obstructive pulmonary disease (COPD), blood pressure, cholesterol and polycystic ovary syndrome (PCOS).
The findings highlight a growing problem in health and wellness advertising: brands are increasingly making claims that suggest medical benefits without providing sufficient evidence that their finished products deliver the promised results.
For advertisers, the report is a reminder that marketing claims must be supported by reliable scientific evidence, particularly when products are promoted for health-related benefits. Medindia+2
60 Nutraceutical Advertisements Required Modification
The ASCI review provides a clear picture of the compliance challenges within India’s nutraceutical advertising market.
Of the 60 advertisements whose assessments were completed, 29 advertisers modified or withdrew their advertisements without contesting ASCI’s objections. The remaining 31 advertisers challenged the objections but failed to provide adequate evidence to support their claims.
This means that every completed case in the review required some form of corrective action.
The findings are significant because they involve different types of products and advertising approaches rather than a single category of supplement.
Some brands promoted rapid weight-loss results, while others highlighted anti-ageing benefits, skin protection or improvements in respiratory health.
ASCI’s concern was not simply whether a product contained a particular ingredient. The organisation examined whether the advertised benefits could be demonstrated for the actual product being sold.
This distinction matters because scientific research on an individual ingredient does not automatically establish that a finished supplement, containing a particular combination of ingredients and dosage, delivers the same results.
For brands, the responsibility is to ensure that the final advertisement accurately reflects what the product can scientifically demonstrate. Medindia+2
Weight Loss and Anti-Ageing Claims Under Advertising Scrutiny
Weight management and anti-ageing are among the most commercially attractive segments of the nutraceutical industry.
Consumers frequently look for products that promise faster weight loss, improved skin appearance, better metabolism and protection against ageing. Brands use these interests to develop advertising campaigns across social media, e-commerce platforms and influencer channels.
However, ASCI’s report identified several claims that lacked adequate substantiation.
Examples highlighted in media coverage included promises such as losing six kilograms in 60 days, eliminating thigh fat within 12 weeks and making skin appear seven years younger.
Another claim suggested a 300% improvement in skin defence against ultraviolet exposure.
Such statements can create specific expectations among consumers. When an advertisement promises measurable physical changes within a fixed period, the advertiser must have appropriate evidence to support the claim.
Before-and-after photographs and dramatic visual comparisons can also influence consumer perceptions. If these visuals exaggerate the actual benefits of a product, they may create misleading impressions.
For nutraceutical brands, the challenge is to distinguish between general wellness communication and claims that imply guaranteed physical or medical outcomes.
A product may be marketed for a permitted nutritional or physiological benefit, but that does not automatically justify promises of rapid or dramatic results. India News – Business Standard+2
Why Ingredient-Level Research Is Not Enough for Health Claims
One of the most important findings in the ASCI report concerns the scientific evidence used by advertisers.
Some brands relied on research conducted on individual ingredients to support claims about their finished products. However, evidence that an ingredient may provide a particular benefit does not automatically prove that a supplement containing that ingredient delivers the same outcome.
The effectiveness of a finished product can depend on several factors:
- Ingredient concentration: The quantity of an ingredient in the product may differ from the amount used in scientific studies.
- Product formulation: Other ingredients can influence how the product works.
- Dosage and consumption: The quantity and frequency of use may affect the outcome.
- Scientific testing: Research must be relevant to the actual formulation and the advertised benefit.
For example, if a study examines a particular ingredient for its potential effect on skin health, a brand cannot automatically use that research to claim that its finished supplement reverses ageing.
The evidence must support the specific product and the specific claim being advertised.
This is particularly important for companies selling products through digital marketplaces, where product descriptions, promotional videos and influencer recommendations can reach large audiences quickly.
ASCI’s findings indicate that brands need stronger documentation before using scientific research in marketing campaigns. India News – Business Standard+2
Disease-Related Claims Raise Concerns About Consumer Safety
Another major concern identified by ASCI involves nutraceutical advertisements that appear to promise benefits associated with treating or managing medical conditions.
Some advertisements made claims involving asthma, COPD, blood pressure, cholesterol, diabetes-related outcomes and PCOS.
These claims can create confusion between nutritional supplements and medical treatments.
Nutraceutical products are intended to provide nutritional or physiological benefits. They should not be presented as substitutes for prescribed medicines or established medical treatment.
For example, a supplement cannot simply claim to reverse asthma or treat PCOS because one of its ingredients has been studied for a possible health benefit.
Such statements require careful examination under applicable food and advertising regulations.
The distinction is important for consumers who may be dealing with chronic health conditions. Misleading advertisements can encourage people to depend on products without understanding their limitations or seeking appropriate medical advice.
Brands should therefore avoid language that suggests their products can cure, reverse or prevent diseases unless the claim is specifically permitted under applicable regulations and supported by the required evidence.
For advertisers, this is not only a compliance issue. It is also a matter of consumer trust and responsible communication. NDTV+2
What FSSAI Rules Say About Nutraceutical Advertising in India
India’s nutraceutical sector operates under the Food Safety and Standards Authority of India’s regulatory framework.
The Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016, establish requirements for the composition, ingredients, labelling and presentation of these products.
The regulations cover different categories, including health supplements, nutraceuticals, probiotic foods, prebiotic foods and functional foods.
These products must meet the applicable conditions prescribed under the framework.
An important distinction is that nutraceuticals are not equivalent to medicines. Their marketing and labelling cannot freely make claims that suggest they diagnose, treat, cure or prevent diseases.
Brands must also ensure that their product descriptions and promotional material do not create an impression that goes beyond the permitted purpose of the product.
For businesses, compliance should begin before a product reaches the market. Product formulation, scientific documentation, packaging, website descriptions and advertising campaigns should be reviewed together.
A claim that appears acceptable in a promotional video may still create regulatory concerns when examined in the context of the product’s actual composition and permitted use.
The FSSAI framework is therefore an important reference for manufacturers, marketers, distributors and digital retailers operating in India’s health supplement industry. FSSAI+2
ASCI Code: Why Advertisers Must Substantiate Every Claim
The Advertising Standards Council of India is a voluntary self-regulatory organisation that monitors advertising practices and addresses complaints involving potentially misleading advertisements.
Its Code requires advertisements to be truthful and prohibits claims that cannot be substantiated.
The responsibility does not rest only with the company selling the product. Advertisers, advertising agencies and media organisations involved in commissioning, creating or publishing advertisements are also expected to follow the Code.
For nutraceutical brands, this means that every objectively verifiable claim should have supporting evidence.
A company advertising a supplement as improving a particular health parameter should be able to demonstrate that the claim is scientifically supported and relevant to the finished product.
Influencer marketing also requires attention.
When creators promote health supplements through paid partnerships or commercial collaborations, they must ensure that their statements are accurate and that material connections with brands are appropriately disclosed.
An influencer cannot make unsupported medical or health claims simply because the company supplied the talking points.
ASCI’s latest findings reinforce the need for better coordination between brand owners, marketing agencies, creators and compliance teams.Advertising Standards Council Of India+2
What Nutraceutical Brands Should Do to Avoid Advertising Violations
The latest ASCI review offers several practical lessons for businesses operating in India’s health and wellness market.
1. Verify claims before launching campaigns
Companies should review all product benefits mentioned in advertisements. Claims about weight loss, skin improvement, immunity and other health outcomes should have appropriate supporting evidence.
2. Maintain product-specific scientific documentation
Brands should not depend only on ingredient-level research. They should maintain evidence relevant to the finished product, including its formulation and recommended dosage.
3. Review influencer marketing content
Influencer scripts, captions, videos and testimonials should undergo compliance checks before publication. Paid partnerships should also include appropriate disclosures.
4. Avoid exaggerated promises
Statements suggesting guaranteed weight loss, disease reversal or dramatic physical changes can create unrealistic consumer expectations. Advertisers should use accurate and appropriately qualified language.
5. Conduct regular website and marketplace audits
Compliance should extend beyond traditional advertisements. Product listings, promotional banners, social media posts and customer-facing descriptions should also be reviewed.
6. Involve legal and regulatory teams
Marketing teams should work with regulatory specialists before approving campaigns involving scientific or medical terminology.
These steps can help businesses reduce compliance risks while maintaining consumer confidence.
Impact on India’s Nutraceutical Industry and Digital Advertising Market
The ASCI findings come at a time when India’s health and wellness market is attracting growing consumer and business interest.
Products such as protein supplements, probiotics, vitamins, herbal formulations, functional beverages and weight-management products have become increasingly visible across e-commerce platforms and social media.
This has created opportunities for manufacturers, direct-to-consumer brands, digital retailers and influencer marketing agencies.
However, increased competition has also encouraged brands to differentiate themselves through stronger product promises and attention-grabbing advertising.
The latest ASCI review highlights why this approach requires greater scrutiny.
For established companies, compliance failures can affect brand reputation and consumer confidence. For emerging startups, advertising violations can create additional costs through campaign modifications, withdrawals and legal reviews.
Smaller brands may face particular challenges because they often depend on influencers and digital advertising agencies to reach customers.
The industry may therefore see greater investment in scientific validation, regulatory consulting and advertising compliance.
For advertising agencies, this also creates a need for specialised teams that understand health-related claims and the regulatory requirements governing nutraceutical promotions.
The long-term opportunity is to build a market where brands compete through product quality, credible evidence and transparent communication rather than exaggerated promises.
What ASCI’s Findings Mean for Consumers
The report is also relevant to consumers who regularly purchase health supplements online.
Many people discover nutraceutical products through Instagram reels, YouTube videos, influencer recommendations and e-commerce advertisements.
Promotional claims involving rapid weight loss, improved skin, better digestion or disease management can influence purchasing decisions.
Consumers should therefore examine product labels, ingredient information, recommended usage and the credibility of health claims before purchasing supplements.
A product being advertised as natural or scientifically researched does not automatically establish that it is effective or suitable for every individual.
Consumers should also avoid replacing prescribed medical treatment with dietary supplements based on advertising promises.
The ASCI findings reinforce the importance of transparent product information and responsible marketing in a category where advertising can directly influence health-related decisions.
What Comes Next for Nutraceutical Advertising in India?
ASCI’s latest review sends a clear message to India’s nutraceutical industry: health and wellness claims must be supported by credible evidence.
As the market expands, companies will need to pay closer attention to scientific documentation, product formulation, influencer communication and regulatory compliance.
The findings could encourage brands to strengthen internal advertising review processes and work more closely with scientific and regulatory experts.
For digital advertising agencies, the report highlights the importance of checking health-related claims before campaigns go live.
The larger issue is consumer trust. Nutraceutical brands operate in a category where customers often make purchasing decisions based on personal health concerns. Misleading promises can damage confidence in individual companies as well as the wider industry.
The future growth of India’s nutraceutical market will depend not only on product innovation and marketing reach but also on how responsibly businesses communicate the benefits of their products.
Key Takeaways
- ASCI reviewed 61 nutraceutical advertisements between July and September 2026, completing 60 cases and finding all 60 required modification.
- Weight-loss, anti-ageing, skincare, UV protection and disease-related claims were among the major areas of concern.
- Ingredient-level research alone is insufficient to substantiate claims about a finished nutraceutical product.
- Brands, advertising agencies and influencers must ensure that health claims are accurate, scientifically supported and compliant with applicable regulations.
Frequently Asked Questions (FAQs)
1. What did ASCI find in its latest nutraceutical advertising review?
ASCI found that all 60 nutraceutical advertisements whose reviews were completed violated its advertising code. The review examined 61 advertisements between July and September 2026, with one case remaining under process.
2. Why were nutraceutical advertisements flagged by ASCI?
Advertisements were flagged mainly because health and wellness claims lacked adequate scientific evidence. Some brands made exaggerated promises about weight loss, anti-ageing, skincare and improvements in medical conditions.
3. Can nutraceutical brands advertise products as treatments for diseases?
Nutraceuticals are not medicines. Under India’s applicable FSSAI framework, brands cannot freely claim that these products treat, cure or prevent diseases. Claims must comply with the relevant regulatory requirements.
4. What should nutraceutical brands do to avoid advertising violations?
Brands should maintain product-specific scientific evidence, verify health claims, review influencer content, avoid exaggerated promises and ensure that product packaging, websites and advertisements comply with applicable FSSAI requirements and the ASCI Code.
Leave a comment